SUMMARY Simultaneous measurements of duodenal and faecal chymotrypsin were made in 30 children aged 3 weeks to 14 years. Apparent chymotrypsin secretion rates measured after stimulation with pancreozymin were compared with the mean faecal chymotrypsin concentration derived from three stool specimens collected at random within 72 hours of the intraduodenal test. In the 25 children who responded to pancreozymin stimulation the mean faecal chymotrypsin concentration was significantly positively correlated with the apparent chymotrypsin secretion rate. Correlation using single specimen stools collected at random was appreciably poorer. In the five children with undetectable or only traces of chymotrypsin in the duodenum after stimulation, the mean faecal chymotrypsin concentrations were only 3-10% of the lower limit of the reference interval. In a second group of 46 children with cystic fibrosis proved by sweat tests and clinical evidence of malabsorption, the chymotrypsin concentration measured in a single stool specimen collected at random was unequivocally subnormal in each case.
In routine clinical practice pancreatic exocrine function is most accurately assessed by measuring the products of pancreatic secretion in fluid from the upper small intestine. 1 Tests requiring intubation of the intestine are, however, technically difficult, expensive, and invasive and there have been many attempts to find an alternative, particularly for the investigation of children. One approach-the measurement of pancreatic proteolytic enzymes in faeces using pancreatic enzyme specific substrateshas been available for many years2 but there is still a lack of concensus about its value. Measurement of faecal chymotrypsin has been recommended by some workers3 4 but other paediatric gastroenterologists discourage it,56 and a firm theoretical basis is required to justify further use of the test. We have therefore sought to validate measurement of faecal chymotrypsin by investigating its performance in two ways: firstly by correlating the results with the activities of chymotrypsin and trypsin in the duodenum after stimulation with pancreozymin and secretin, and secondly by measuring its ability to identify the defect in known cases of pancreatic exocrine insufficiency. 
Results

DUODENAL FLUID ENZYMES
Of the 30 children studied, 25 responded to the pancreozymin stimulation. Twenty four had apparent trypsin secretion rates above the lower limit of the control range that was defined by Hadorn8 and confirmed in this department (fig 1) , and one was below. In the remaining five tests, the apparent trypsin secretion rates were grossly subnormal with no enzyme activity detectable in three and traces only in two.
The apparent chymotrypsin secretion rates were segregated in the same way. The five children who failed to produce a trypsin response after stimulation with pancreozymin also failed to produce a chymotrypsin response. The child that produced a measurable but subnormal apparent trypsin secretion rate also had a subnormal apparent secretion rate of chymotrypsin of only 30% of the lower limit (mean 
Discussion
In the study correlating duodenal enzyme activities and faecal concentrations, mean faecal chymotrypsin concentrations derived from three separate stool specimens collected at random within 72 hours of the intraduodenal test were highly significantly correlated with the apparent secretion rates of chymotrypsin. The correlation applied whether pancreatic function was compromised or within the physiological range, with the result that the segregation in the apparent secretion rates of chymotrypsin between normal pancreatic function and pancreatic insufficiency was reproduced identically by the mean faecal chymotrypsin concentrations. In the 46 children with cystic fibrosis and clinical evidence of malabsorption faecal chymotrypsin concentrations were without exception grossly subnormal.
Various measures of correlation have been reported in adults between: duodenal output of chymotrypsin and output in 24 hour stool collections9; duodenal output of trypsin and chymotrypsin concentrations in stool specimens collected at random'(; and duodenal concentration of chymotrypsin and faecal concentration." None, however, correlated chymotrypsin secretion rates with chymotrypsin concentration in stool specimens collected at random-the only specimens that are readily available in infants and young children. There have been no correlation studies reported in children.
It was necessary to use multiple faecal analyses to achieve the degree of association between duodenal and faecal measurements that we have shown. Using only the results from the first of the three stool analyses for correlation produced a significantly lower degree of association. Homogeneity of chymotrypsin distribution has been claimed both within the individual stool12 and between three stool specimens collected at random on separate days.11
This may be what usually happens, but our experience has been that the occurrence of comparatively unrepresentative results from analysis of a single stool specimen is sufficiently frequent to make multiple analyses essential. Four of the 75 individual stool analyses in the correlation study differed by more than 50% (median value=14%) from the mean value of their relevant triplicates, and the largest deviation was 84%. Such differences are quite large enough to give rise to misinterpretation of single results at the lower limit of the reference range.
Other workers have also emphasised this point, recommending the use of two'( or more13 stool specimens collected at random. Moeller'3 found three of 22 faecal chymotrypsin results from nine adults with pancreatic exocrine insufficiency within their control range. By repeat testing and using mean values all false negatives were eliminated. We recommend the use of three specimens collected at random. If all three stool specimens produce chymotrypsin concentrations significantly greater than the lower limit of the reference range, pancreatic insufficiency at the time of the investigation can be excluded. This would not be true for specific lipase, co-lipase, or trypsinogen deficiencies but these conditions are extremely rare.
In the 46 children with cystic fibrosis and clinically recognised malabsorption, faecal chymotrypsin concentrations were unequivocaily subnormal, and single stool specimens were sufficient to identify the gross pancreatic insufficiency characteristic of the disease. The children were selected for the present study because they had malabsorption and it was not considered ethically justifiable to confirm the degree of pancreatic insufficiency by intubation and hormone stimulation.
Controversy persists over the efficiency of faecal chymotrypsin measurement as a method of assessing pancreatic function because of confusion over the function and capability of the test. The test may not detect the initial stages of insufficiency in developing disease. It cannot differentiate between normal pancreatic function and chronic pancreatitis where secretion (though invariably ultimately compromised) may initially be normal, and pancreatic carcinoma where reduced secretion (if it occurs) depends on the site and nature of the lesion. The reputation of the test has suffered because it does not resolve these 'adult' problems.
In addition to the difference in the clinical questions being asked, there may be other reasons for greater specificity in children. Mean whole gut transit times are shorter in children, the transit time of the neonate14 being about a quarter of that of the adult.'5 The shorter transit time reduces the opportunity for bacterial'6 and enzymatic'7 degradation in transit, making the test more direct and increasing its specificity. Reducing adult whole gut transit time with purgatives to about that of the neonate improves the duodenal faecal chymotrypsin correlation.9
